MRUS
Merus N.V.
Company Overview
| Mkt Cap | $7.18B | Price | $94.86 |
| Volume | 1.08M | Change | -0.21% |
| P/E Ratio | -33.3 | Open | $95.02 |
| Revenue | $36.1M | Prev Close | $95.06 |
| Net Income | $-215.3M | 52W Range | $33.19 - $95.30 |
| Div Yield | N/A | Target | $95.77 |
| Overall | 53 | Value | 40 |
| Quality | 44 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyMerus N.V. (MRUS) is a leading Healthcare company in the Biotechnology industry, currently trading at $94.86 with a market capitalization of $7.18 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows MRUS with a volume of 1.08 million shares. The stock opened down 0.04% from yesterday's close of $95.06. Current analyst estimates project earnings of $-5.9 per share for this year, with next year targeting $-5.35.
MRUS demonstrates strong technical indicators based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for MRUS include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 1.0%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 10:58 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MRUS | $94.86 | -0.2% | 1.08M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |